
CAS 1492952-76-7
:3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
Description:
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)- is a complex organic compound characterized by its multi-functional structure, which includes a pyridine ring, a pyrazole moiety, and a pyrrolidine derivative. The presence of a chlorodifluoromethoxy group indicates potential applications in medicinal chemistry, particularly in the development of pharmaceuticals, due to its ability to modulate biological activity. The compound's molecular architecture suggests it may exhibit specific interactions with biological targets, potentially influencing its pharmacokinetic and pharmacodynamic properties. Additionally, the hydroxyl group on the pyrrolidine ring may enhance solubility and bioavailability. The compound's unique combination of functional groups may also contribute to its stability and reactivity, making it a subject of interest for further research in drug design and synthesis. As with many compounds of this nature, safety and handling precautions should be observed, particularly due to the presence of halogenated groups, which can pose environmental and health risks.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
CAS:Formula:C20H18ClF2N5O3Purity:98%Color and Shape:SolidMolecular weight:449.8384Asciminib
CAS:<p>Asciminib (ABL001) (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).</p>Formula:C20H18ClF2N5O3Purity:98.82% - 99.70%Color and Shape:SolidMolecular weight:449.84Asciminib
CAS:<p>BCR-ABL tyrosine kinase inhibitor; antineoplastic</p>Formula:C20H18ClF2N5O3Purity:Min. 95%Molecular weight:449.84 g/mol





